Compass Therapeutics (CMPX) Stock Price, Quote, News & History

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga

Benzinga

Compass Therapeutics Inc (CMPX) Stock Price, Quote, News & History

Key Statistics

Recent Compass Therapeutics Inc. News

Compass Therapeutics' Bile Duct Cancer Drug Seen As New Standard Of Care

Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer

Compass Therapeutics' Combo Therapy Shows Around 38% Overall Response Rate In Pretreated Biliary Tract Cancer Patients

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Compass Therapeutics (CMPX) stock?

Who are Compass Therapeutics (CMPX) competitors?

What is the forecast, or price target, for Compass Therapeutics (CMPX) stock?

What is the current price for Compass Therapeutics (CMPX)?

Does Compass Therapeutics (CMPX) pay a dividend?

When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?

Is Compass Therapeutics (CMPX) going to split?

What sector and industry does Compass Therapeutics (CMPX) operate in?

People Also Watch

Key Statistics

Recent Compass Therapeutics Inc. News

Compass Therapeutics' Bile Duct Cancer Drug Seen As New Standard Of Care

Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer

Compass Therapeutics' Combo Therapy Shows Around 38% Overall Response Rate In Pretreated Biliary Tract Cancer Patients

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

Compare

FAQ

How do I buy Compass Therapeutics (CMPX) stock?

Who are Compass Therapeutics (CMPX) competitors?

What is the forecast, or price target, for Compass Therapeutics (CMPX) stock?

What is the current price for Compass Therapeutics (CMPX)?

Does Compass Therapeutics (CMPX) pay a dividend?

When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?

Is Compass Therapeutics (CMPX) going to split?

What sector and industry does Compass Therapeutics (CMPX) operate in?

People Also Watch

Bulls vs Bears